Real-world impact of the fixed-dose combination on improving treatment outcomes of drug-susceptible tuberculosis: a comparative study using multiyear national tuberculosis patient data

BACKGROUND: The fixed-dose combination (FDC) for first-line antituberculosis (TB) treatment has long been a standard practice worldwide; however, there is limited evidence on whether the use of FDC improves long-term treatment outcomes in the real-world setting. METHODS: We identified 32 239 newly d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ki, Min Seo, Jeong, Dawoon, Kang, Hee-Yeon, Choi, Hongjo, Sohn, Hojoon, Kang, Young Ae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Tuberculosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626786/
https://www.ncbi.nlm.nih.gov/pubmed/37918950
http://dx.doi.org/10.1136/bmjresp-2023-001758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626786/
https://www.ncbi.nlm.nih.gov/pubmed/37918950
http://dx.doi.org/10.1136/bmjresp-2023-001758

Ejemplares similares